Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors
Top Cited Papers
Open Access
- 18 March 2016
- journal article
- Published by Wiley in Aging Cell
- Vol. 15 (3), 428-435
- https://doi.org/10.1111/acel.12445
Abstract
Clearing senescent cells extends healthspan in mice. Using a hypothesis‐driven bioinformatics‐based approach, we recently identified pro‐survival pathways in human senescent cells that contribute to their resistance to apoptosis. This led to identification of dasatinib (D) and quercetin (Q) as senolytics, agents that target some of these pathways and induce apoptosis preferentially in senescent cells. Among other pro‐survival regulators identified was Bcl‐xl. Here, we tested whether the Bcl‐2 family inhibitors, navitoclax (N) and TW‐37 (T), are senolytic. Like D and Q, N is senolytic in some, but not all types of senescent cells: N reduced viability of senescent human umbilical vein epithelial cells (HUVECs), IMR90 human lung fibroblasts, and murine embryonic fibroblasts (MEFs), but not human primary preadipocytes, consistent with our previous finding that Bcl‐xl siRNA is senolytic in HUVECs, but not preadipocytes. In contrast, T had little senolytic activity. N targets Bcl‐2, Bcl‐xl, and Bcl‐w, while T targets Bcl‐2, Bcl‐xl, and Mcl‐1. The combination of Bcl‐2, Bcl‐xl, and Bcl‐w siRNAs was senolytic in HUVECs and IMR90 cells, while combination of Bcl‐2, Bcl‐xl, and Mcl‐1 siRNAs was not. Susceptibility to N correlated with patterns of Bcl‐2 family member proteins in different types of human senescent cells, as has been found in predicting response of cancers to N. Thus, N is senolytic and acts in a potentially predictable cell type‐restricted manner. The hypothesis‐driven, bioinformatics‐based approach we used to discover that dasatinib (D) and quercetin (Q) are senolytic can be extended to increase the repertoire of senolytic drugs, including additional cell type‐specific senolytic agents.Keywords
Funding Information
- National Institutes of Health (AG13925, DK50456, AG043376)
- American Federation for Aging Research
- National Natural Science Foundation of China (81572948)
This publication has 30 references indexed in Scilit:
- BH3 Mimetics: Status of the Field and New DevelopmentsMolecular Cancer Therapeutics, 2013
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunitiesJCI Insight, 2013
- Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescenceNature Communications, 2012
- Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1Breast Cancer Research and Treatment, 2011
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disordersNature, 2011
- Deciphering the rules of programmed cell death to improve therapy of cancer and other diseasesThe EMBO Journal, 2011
- Fat tissue, aging, and cellular senescenceAging Cell, 2010
- Aging, Depot Origin, and Preadipocyte Gene ExpressionThe Journals of Gerontology: Series A, 2010
- Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer TherapyClinical Cancer Research, 2009
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007